Aptissen S.A. is a Swiss company specialising in the development and marketing of medical devices based on biopolymers. The founders of Aptissen have developed over the last 25 years injectable products of the highest quality that meet the expectations of patients and physicians: www.aptissen.com The company was founded in 2013 as a spin-off of ANTEIS, and is based in the Geneva region, Switzerland. It now distributes its products through an international network of distributors in more than 90 countries, including Europe, South America, Canada, the Middle East and Asia. Aptissen's team has revolutionised the viscosupplement market with Synolis VA and its patented formulation combining hyaluronic acid and sorbitol. Synolis VA allows rapid recovery of mobility, rapid and long-lasting pain relief combined with excellent safety: www.synolis.com We place patient benefit at the centre of our mission to develop innovative injectable solutions based on hyaluronic acid for rapid pain relief.
